Biomark Diagnostics (FRA:20B) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics Days Payable?

Biomark Diagnostics's average Accounts Payable for the three months ended in Dec. 2023 was €0.13 Mil. Biomark Diagnostics's Cost of Goods Sold for the three months ended in Dec. 2023 was €0.00 Mil.

The historical rank and industry rank for Biomark Diagnostics's Days Payable or its related term are showing as below:

FRA:20B's Days Payable is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 66.645
* Ranked among companies with meaningful Days Payable only.

Biomark Diagnostics's Days Payable stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00). stayed the same

Biomark Diagnostics Days Payable Historical Data

The historical data trend for Biomark Diagnostics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Days Payable Chart

Biomark Diagnostics Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Payable

Get a 7-Day Free Trial

Biomark Diagnostics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Biomark Diagnostics's Days Payable

For the Diagnostics & Research subindustry, Biomark Diagnostics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomark Diagnostics's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's Days Payable distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's Days Payable falls into.

Biomark Diagnostics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Biomark Diagnostics's Days Payable for the fiscal year that ended in Mar. 2023 is calculated as

	Days Payable (A: Mar. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2022 )	+	Accounts Payable (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (0.092	+	0.15)	/	2 )	/	0	*	365
=	0.121					/	0	*	365
=	N/A

Biomark Diagnostics's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.204	+	0.056)	/	2 )	/	0	*	365 / 4
=	0.13					/	0	*	365 / 4
=	N/A

Biomark Diagnostics Days Payable Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomark Diagnostics (FRA:20B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (FRA:20B) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

BMKDF:USA BUX:Canada

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Biomark Diagnostics (FRA:20B) Headlines

No Headlines